Chloramphenicol + FlurbiprofenThird Party Manufacturing in India

Chloramphenicol + Flurbiprofen works by pairing a broad-spectrum bacteriostatic antibiotic with a potent non-steroidal anti-inflammatory drug. Chloramphenicol binds reversibly to the 50S ribosomal subunit of susceptible bacteria to inhibit protein synthesis, while flurbiprofen inhibits the cyclooxygenase enzyme to arrest prostaglandin synthesis. This dual action helps the body eliminate bacterial loads while blocking the inflammatory cascade. Unlike steroid-antibiotic combinations, it manages severe inflammation without risking elevations in intraocular pressure. It is highly effective and well-tolerated.

Therapeutic Uses

• Infectious Ocular Inflammation: Formulated for the treatment of surface ocular infections accompanied by severe pain, swelling, or redness.
• Post-Surgical Prophylaxis: Administered post-operatively to prevent bacterial infection and reduce localized surgical swelling simultaneously.

Why Manufacturers Choose Chloramphenicol + Flurbiprofen

Chloramphenicol + Flurbiprofen third party manufacturing in India is a major asset for brands focusing on clinical post-operative eye care. By replacing separate antibiotic and anti-inflammatory drops with a single unified solution, patient adherence increases exponentially. Celesta relies on a strict manufacturing framework where partner facilities are WHO-GMP certified, ensuring perfect stability of both molecules in a sterile medium. This high-demand therapeutic item fits ideally into any hospital or retail distribution supply chain under WHO-GMP certification.